about
Cancer Stem Cell Hierarchy in Glioblastoma MultiformeBiology of infantile hemangiomaElevated Serum Levels of Alpha-Fetoprotein in Patients with Infantile Hemangioma Are Not Derived from within the TumorCharacterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma.Cancer Stem Cells in Glioblastoma Multiforme.Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin-Angiotensin SystemCancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System.Embryonic Stem Cell-like Population in Dupuytren's Disease.Pharmacologic therapies for infantile hemangioma: is there a rational basis?PHACE syndrome--clinical features, aetiology and management.Does hypoxia play a role in infantile hemangioma?Expression of Cathepsins B, D, and G in Infantile Hemangioma.Expression of the Components of the Renin-Angiotensin System in Venous Malformation.Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma express components of the renin-angiotensin system.Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma.Mast cells in infantile haemangioma possess a primitive myeloid phenotype.Gold weight implantation and lateral tarsorrhaphy for upper eyelid paralysis.Neuropeptide Y receptor 1 is expressed by B and T lymphocytes and mast cells in infantile haemangiomas.PHACE(S) Syndrome With Absent Intracranial Internal Carotid Artery and Anomalous Circle of Willis.Tumour stem cells in meningioma: A review.Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function.Characterisation of lymphocyte subpopulations in infantile haemangioma.Characterisation of subpopulations of myeloid cells in infantile haemangioma.Angiotensin II causes cellular proliferation in infantile haemangioma via angiotensin II receptor 2 activation.Omental whirl: torsion of the greater omentum.Changing prevalence and treatment outcomes of patients with p16 human papillomavirus related oropharyngeal squamous cell carcinoma in New Zealand.Infantile haemangioma expresses embryonic stem cell markers.Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL).Primitive erythropoiesis in infantile haemangioma.Mesenchymal stem cells in infantile haemangioma.Thoracic splenosis: a treatment approachReply to the letter to the Editor on "Low-dose propranolol for infantile haemangioma"Treatment of infantile haemangioma with captoprilLow-dose propranolol for infantile haemangiomaSpontaneously reduced isolated orbital roof fracturePrimitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangiomaA placental chorionic villous mesenchymal core cellular origin for infantile haemangiomaExpression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involutionHaemogenic endothelium in infantile haemangiomaAngiolymphoid hyperplasia with eosinophilia developing within a port wine stain
P50
Q26752312-C0367DE2-F463-4675-AF32-267480EB6176Q34867993-DE3E6651-F767-4A77-AEEF-0100EE0E29EBQ36558970-4257E991-7E2F-4E2A-8871-E240F1845022Q37146238-C2175131-BB20-4BB7-9ED1-3071C4A69406Q37210629-84992153-C74D-443C-B498-BBBF665051F3Q37284738-3E5153CF-C88E-4C52-83BF-F663FA84F239Q37284841-2261F247-6570-4E32-B3EE-BEECE828D9E8Q37481424-2BF6801A-162D-44A8-A5D2-E5704FF56542Q37905487-C84AEA6F-24FB-4926-A6EF-9EECD2B856A1Q38607717-71684681-C374-4FCF-B6A6-5C1D1A3A77EDQ38759884-CD74EA99-7EE7-4597-9B2E-196B38F0E21CQ40773699-AE13205F-F98E-429B-B2A3-431EEC9B33FFQ40885805-74A48B75-B471-4442-BC92-D577FE73FF5BQ41320360-A435F424-4950-4EF5-BF38-05C9E909B0DEQ42376795-7A868139-C35C-454F-AB92-95C3221F5EACQ43504267-667D02FF-4DFF-4D73-B4D6-7EA95CDE89F8Q46790814-3736FA26-7A56-4F97-87E2-DDBE12E1ED74Q47849205-6A633AE6-13AA-436C-B04E-4477EE813049Q48126112-CB9E8498-CAE9-4466-A5D3-5577EF65D50DQ50117591-E775139F-1388-412D-912B-5A67560520D4Q51887696-A47320B3-C0A8-4C8F-B57C-DA51DD442703Q53469895-8BDE2E8B-6170-461E-B1A6-E7915E8D5C4BQ53558648-B2E7C311-72A7-45D1-892F-B75989EF6A70Q53604633-4F600B03-D76D-4088-AF73-29EB6366E3B8Q53614393-7C955789-0826-4FBF-B7F3-21CA8A8284E6Q54187088-F90B17E6-E16C-40BB-A18F-A71CDC1EB4BBQ54317546-BDD99557-11C2-44C2-9A94-255890EB65BFQ54341977-55F838F6-B08B-410A-8DDB-E58FA96BBD56Q54376198-361FEECA-726D-44C7-A52F-29AF038BDAFDQ54392250-CC29AF17-F029-4CA0-9A48-CB39C064F0D8Q83161128-BBC3FEFF-CAC7-46DC-B23D-556A874B43D0Q83297602-C9D3B4AC-23F3-4195-B5D7-5A1CEB4F133BQ83991158-46C4111F-EAD6-4D4C-9EEA-21CF98FE9115Q84547825-DD3F97E5-50EA-45EF-A75B-2148AAD3E8CAQ84577295-BA79EFEF-08F4-4CAE-8E39-E45F3ED700A3Q84705425-A93F12A7-388C-46BD-B081-89FC6C9F1449Q84985945-675534BA-E594-43DF-80A4-8AB02193F9B9Q85093030-8C5819C9-999D-4D16-9E15-D0F4461BEA4EQ85160522-6842FF3A-30D2-4CCB-8885-912D428F212CQ85210252-1D9620FF-1A35-4301-8F58-3B1469671BCE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tinte Itinteang
@ast
Tinte Itinteang
@en
Tinte Itinteang
@es
Tinte Itinteang
@sl
type
label
Tinte Itinteang
@ast
Tinte Itinteang
@en
Tinte Itinteang
@es
Tinte Itinteang
@sl
prefLabel
Tinte Itinteang
@ast
Tinte Itinteang
@en
Tinte Itinteang
@es
Tinte Itinteang
@sl
P106
P2798
P31
P496
0000-0001-8079-9059